Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220308054220N1Phase 3Completed
Phase 3, randomised, double-blind trial comparing Placebo control with Intravenous paracetamol (2 arms). Primary endpoint: Pain assessment by Visual Analogue Scale. Started May 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220308054220N1.